J Yeungnam Med Sci Search


J Yeungnam Med Sci > Volume 39(1); 2022 > Article
Song, Shin, Na, Han, Choi, and Lee: Clinical investigation on acute pyelonephritis without pyuria: a retrospective observational study



The current guidelines for the diagnosis of acute pyelonephritis (APN) recommend that APN be diagnosed based on the clinical features and the presence of pyuria. However, we observed that some of the patients who are diagnosed with APN do not have characteristic clinical features or pyuria at the initial examination. We performed this study to investigate the characteristics of APN without pyuria.


A retrospective, cross-sectional study was conducted on 391 patients diagnosed with APN based on clinical and radiologic findings, between 2015 and 2019. The clinical features, laboratory results, and computed tomography (CT) findings were compared between patients with normal white blood cell (WBC) counts and those with abnormal WBC counts (WBC of 0–5/high power field [HPF] vs. >5/HPF) in urine.


More than 50% of patients with APN had no typical urinary tract symptoms and one-third of them had no costovertebral angle (CVA) tenderness. Eighty-eight patients (22.5%) had normal WBC counts (0–5/HPF) on urine microscopy. There was a negative correlation between pyuria (WBC of >5/HPF) and previous antibiotic use (odds ratio, 0.249; 95% confidence interval, 0.140–0.441; p<0.001), and the probability of pyuria was reduced by 75.1% in patients who took antibiotics before visiting the emergency room.


The diagnosis of APN should not be overlooked even if there are no typical clinical features, or urine microscopic examination is normal. If a patient has already taken antibiotics at the time of diagnosis, imaging studies such as CT should be performed more actively, regardless of the urinalysis results.


Acute pyelonephritis (APN) is characterized by upper urinary tract infection (UTI) symptoms (fever and flank pain) and pyuria [1,2]. However, symptoms related to upper UTI may be ambiguous, and sometimes only fever may appear [3,4]. If the symptoms presented by the patient are ambiguous or no symptoms other than fever are present, an objective test confirming the presence of pyuria is an important factor in the diagnosis of APN [5-7]. However, it is known that some patients diagnosed with APN do not have pyuria [8], which is frequently encountered in clinical practice.
In this study, we investigated the number of white blood cells (WBC) observed in urine microscopy of female patients who were finally diagnosed with APN, to analyze how many patients with APN do not have pyuria, and to determine the differences in demographics, medical history, clinical features, physical examination findings, laboratory examination results, and abdominal computed tomography (CT) findings between APN with and without pyuria.


Ethical statements: This study was conducted as a retrospective, cross-sectional study after receiving approval from the Institutional Review Board (IRB) of Kangbuk Samsung Hospital (IRB No: 2020-11-030). The patient’s name, hospital number, date of birth, and social security number were deleted after assigning a serial number to each to maintain anonymity.

1. Subjects

In addition to the clinical diagnosis of APN, abdominal CT findings compatible with APN were also necessary to target only patients with a clear APN diagnosis. Female patients aged 18 years or older who visited our emergency department (ED) between January 2015 and December 2019 and whose final discharge diagnosis was APN were sought. Then, the CT findings were reviewed to exclude cases that did not have findings compatible with APN or had obvious causes of infection other than APN. In addition, patients who visited the hospital with a double J stent, percutaneous nephrostomy, and an indwelling foley catheter were also excluded (Fig. 1).

2. Outcome measures

The urine WBC counts of the subjects determined by the microscopic study were arbitrarily classified into WBC 0–3/HPF, 4–5/HPF, 6–10/HPF, 11–20/HPF, and >20/HPF. We investigated the number of patients with APN having urine WBC counts in the normal range (0–5/HPF). After that, we compared the demographic characteristics, medical history, clinical features, physical examination findings, laboratory results, and CT findings between patients with normal WBC counts and those with abnormal WBC counts (0–5/HPF vs. >5/HPF). The patient’s age, underlying disease, past APN diagnosis experience, time from symptom onset to diagnosis, and antibiotic use prior to the ED visit were determined under demographic characteristics and medical history. It was not possible to determine the dose, duration, and type of antibiotics administered, and it was defined as “previous antibiotics use” if the patient took antibiotics even once before visiting the emergency room. The symptoms of upper UTI (fever and flank pain) and lower UTI (dysuria, frequency, urgency and residual urine sense) were recorded under clinical features. Costovertebral angle (CVA) tenderness was investigated for physical examination findings. WBC, neutrophil-to-lymphocyte ratio (NLR), C-reactive protein (CRP), procalcitonin, urine culture results, and blood culture results were investigated for laboratory findings. A positive urine culture test was defined as >105 colony-forming unit/mL. APN was defined as wedge-shaped low attenuation lesions from the renal medulla to the renal cortex and/or perinephric fat stranding on enhanced CT, and perinephric fat stranding on nonenhanced CT [9,10]. In addition, renal abscess formation and emphysematous change were considered APN. Those who had ureteritis or cystitis without APN were excluded from the study.

3. Statistical analysis

Statistical analysis was performed using STATA (STATA 15.1, StataCorp LLC, College Station, TX, USA). Continuous variables are presented as mean and standard deviation, and categorical variables are described in terms of frequency (%). Continuous variables were compared using the Student t-test or Mann-Whitney U-test, while categorical variables were compared using the chi-square or Fisher exact test, according to the expected frequency. Statistical significance was set at p<0.05. Logistic regression was performed to confirm the correlation of major variables according to the amount of WBCs observed in the urine microscopic study. Multivariate logistic regression was performed using the variables considered to have an important effect on the presence of pyuria, with a p-value of 0.05 or less in univariate analysis.


1. General characteristics

The average age of patients was 58.5 years, and the average time to visit the emergency room after symptom onset was 69.3 hours. Sixty-two patients (15.9%) had already taken antibiotics at least once before visiting the ED. More than 90% of patients with APN had a fever or a history of fever. Approximately 43.2% of patients had upper UTI symptoms (back pain or flank pain), and only 39.9% of patients had lower UTI symptoms (dysuria, frequency, urgency, and residual urine sense) at the time of ED visit. More than 50% of patients with APN did not have either upper or lower UTI symptoms. On physical examination, CVA tenderness was observed in 269 patients (68.8%), and approximately one-third of patients did not have CVA tenderness despite APN.
A total of 223 patients underwent blood culture, and pathogens were identified in 80 patients (35.9%). Among the 138 patients who underwent urine culture, 99 (71.7%) had pathogenic bacteria.
On abdominal CT, 89 patients did not have findings compatible with APN despite the clinical diagnosis of APN. There were 49 patients who had other causes of infection without APN findings on abdominal CT despite the clinical diagnosis of APN. Abscess formation or emphysematous changes were observed on abdominal CT in 24 patients (6.1%). There were 175 patients (44.8%) with ureteritis and 131 patients (33.5%) with cystitis (Table 1).

2. Comparison of patients with normal (0–5/HPF) and abnormal WBC count (>5/HPF) in urine microscopic study

Eighty-eight patients (22.5%) had normal WBC counts (0–5/HPF) despite the clinical and CT diagnosis of APN, whereas 77.5% of patients had abnormal WBC counts (>5/HPF) on urine microscopic analysis (Table 2).
When comparing APN with normal WBC (0–5/HPF) and with abnormal WBC (>5/HPF), there were no differences in age, underlying disease, duration from symptom onset to diagnosis, previous history of APN, upper UTI symptoms (fever and flank pain), lower UTI symptoms (dysuria, frequency, urgency, and residual urine sense), physical examination findings, blood WBC count, CRP, procalcitonin, and positive blood culture results. The variables that showed statistical differences were prior use of antibiotics, neutrophil percentage, NLR, and positive urine culture. Abscess formation or emphysematous changes in abdominal CT showed no difference, while ureteritis or cystitis showed a significant difference. Patients with APN accompanied by ureteritis or cystitis on CT showed a significantly higher prevalence of abnormal WBC counts (>5/HPF) on urine microscopic examination (Table 3).

3. Logistic regression analysis

Table 4 shows the results of the univariate and multivariate logistic regression analyses. Among the variables with a p<0.05 in univariate analysis, previous antibiotic use, ureteritis, and cystitis were presumed to have an important effect on pyuria, and multivariate logistic regression analysis was performed using these variables. There was no multicollinearity between ureteritis and cystitis (phi coefficient=0.200). There was a strong and independent negative correlation between WBC of >5/HPF and previous antibiotic use at the time of diagnosis (odds ratio [OR]), 0.249; 95% confidence interval [CI], 0.140–0.441; p<0.001). If antibiotics were used at least once before visiting the emergency room, the chance of pyuria in urinalysis was reduced by 75.1%. None of the clinical signs or symptoms correlated with pyuria. Among the blood test results, neutrophil percentage and NLR showed a minimal positive correlation. For every one-unit increase in neutrophil percentage and NLR, the probability of pyuria was predicted to increase by 3.3% and 5.1%, respectively. The probability of pyuria was significantly higher in cases with ureteritis or cystitis on CT than in those without ureteritis or cystitis. In particular, in bilateral ureteritis, the OR for pyuria reached 9.7 (95% CI, 2.2–41.7; p=0.002) compared to cases without ureteritis.


This study showed that a relatively large proportion of patients with a confirmed diagnosis of APN based on clinical and radiological findings did not have typical clinical features and WBC counts on urine microscopic examination were within the normal range. Unlike the current guidelines for diagnosing APN based on clinical features and pyuria, this result suggests that it is difficult to exclude the diagnosis of APN based on clinical features and pyuria alone.
Eighty-eight patients (22.5%) had normal WBC counts (0–5/HPF) on urine microscopic examination despite the clinical and CT diagnosis of APN. Among the several variables investigated, even a single use of antibiotics before visiting the ED was found to be highly correlated with normal urine WBC counts despite having APN. Therefore, prior use of antibiotics before ED visit should always be checked while taking a patient’s history for APN diagnosis. If the patient has already taken antibiotics, it is reasonable to diagnose APN based on the results of imaging tests such as CT rather than the results of urinalysis.
On the other hand, the presence of abnormal WBC count showed a significant positive correlation with the presence of accompanying ureteritis or cystitis on CT. UTI is a retrograde ascending infection in which uropathogens arising from fecal flora, progress through the urethra and bladder to the ureter and kidney [11,12]. Clinical features appear in the form of urethritis and cystitis at the onset of UTI; hence, typical symptoms of lower UTI, such as dysuria, frequency, residual urine sense, and urgency are observed. However, as UTI progresses to ureteritis and pyelonephritis, upper UTI symptoms (fever and flank pain) appear. As lower UTI progresses to APN, the uropathogens may move from the lower urinary tract to the upper region of the tract; hence, bacteria and inflammation no longer remain in the lower urinary tract. However, in other cases, bacteria and inflammation may remain in the lower urinary tract. We assumed that if bacteria and inflammation remain in the lower urinary tract in patients with APN, cystitis should be observed along with APN findings on CT, and urine WBC count may be high.
This study showed that more than half of patients with APN had neither upper UTI symptoms nor lower UTI symptoms, and approximately one-third of patients had no CVA tenderness. It is known that elderly patients with APN can only have a fever without typical symptoms of UTI [3,4]. However, in this study, the subjects were from a relatively younger age group with an average age of 58.5±18.7 years, which indicates that even in young female patients, typical upper UTI symptoms and lower UTI symptoms may not appear in APN. Physicians should always keep in mind that clinical features and physical examination may be ambiguous, and pyuria may not be present in patients with APN.
The current APN diagnosis and treatment guidelines recommend that APN be diagnosed clinically based on the clinical features and the presence of pyuria, and to perform imaging studies only if the patient does not show clinical improvement after 72 hours of antibiotic treatment [1,2,13]. However, complicated APN requiring intervention or maintenance on a longer period of antibiotic treatment (kidney abscess, emphysematous change, ureter stone, etc.) is only identified after CT scans [8,14-16]. Moreover, as shown in the results of this study, there were many cases without APN findings or other infection sources than APN on CT, despite the clinical suspicion of APN. In this study, 16.4% of cases (89 of 542) had no evidence of APN on CT, and 9.0% of patients (49 of 542) with the clinical suspicion of APN had other sources of infection than APN on CT. For these reasons, the effectiveness of CT in APN diagnosis is gradually increasing. The authors recommend to actively perform CT on patients from their initial visit if APN cannot be ruled out, rather than insisting on the current guidelines that defer imaging studies.
The main limitation of this study could be the selection bias. First, since this study was not intended for all patients with clinically suspected APN, but only for patients who had confirmed APN based on CT scan, there is a possibility that a selection bias could have occurred. Some patients may not have undergone CT because their symptoms, physical examination findings, and urine microscopy results were clearly suggestive of APN. These patients could have been included in the study if they had undergone CT. Second, this study included only patients who visited the ED; hence, patients who visited the outpatient clinic were excluded. Third, this was a single-center, retrospective study. Additionally, we have not studied whether there are differences in treatment and clinical prognosis between patients with and without pyuria.
More than half of the patients with confirmed APN did not have typical symptoms or signs of UTI, and about one-quarter of the patients did not have pyuria. Usage of antibiotics before ED visit was strongly and independently correlated with normal WBC counts on urinalysis. The diagnosis of APN should not be overlooked even if there are no typical clinical features, or a urine microscopic analysis is normal. If no other cause of fever can be found and APN cannot be completely excluded, imaging tests such as CT should be more actively performed regardless of clinical features or presence of pyuria, especially if the patient has already taken antibiotics at the time of diagnosis.


Conflicts of interest

No potential conflict of interest relevant to this article was reported.

Author contributions

Conceptualization: all authors; Data curation, Investigation: HKS, JHL, DHS, JUN; Formal analysis: HKS, JHL, JUN, SKH, PCC; Supervision: DHS, JUN, SKH, PCC; Writing-original draft: HKS, JHL; Writing-review & editing: HKS, JHL, DHS, JUN, SKH, PCC.

Fig. 1.
Flow diagram of the enrolled patients. APN, acute pyelonephritis; ED, emergency department; CT, computed tomography; DJ, Double J; PCN, percutaneous nephrostomy.
Table 1.
Demographic data
Characteristic Data
No. of patients 391
Age (yr) 58.5±18.7
Symptom onset to ED (hr) 69.3±109.1
Past medical history
 Diabetes mellitus 118 (30.2)
 Hypertension 152 (38.9)
 Chronic kidney disease 14 (3.6)
 Previous APN history 92 (23.5)
 Previous antibiotics use at least once before ED visit 62 (15.9)
Clinical presentation
 Fever 361 (92.3)
 Back pain or flank pain 169 (43.2)
 Lower UTI symptom
  Dysuria 142 (36.3)
  Frequency 185 (47.3)
  Urgency 89 (22.8)
  Residual urine sense 97 (24.8)
 CVA tenderness 269 (68.8)
Abdomen CT finding
 Abscess formation or emphysematous change 24 (6.1)
 Ureteritis 175 (44.8)
 Cystitis 131 (33.5)
 Urine culture positive 99/138 (71.7)
 Blood culture positive 80/223 (35.9)

Values are presented as number only, mean±standard deviation, or number (%).

ED, emergency department; APN, acute pyelonephritis; UTI, urinary tract infection; CVA, costovertebral angle; CT, computed tomography.

Table 2.
Degree of leukocyte in urine microscopy study among acute pyelonephritis confirmed patients in the emergency department
Degree of WBC Data
0–3/HPF 46 (11.8)
4–5/HPF 42 (10.7)
6–10/HPF 61 (15.6)
11–20/HPF 68 (17.4)
>20/HPF 174 (44.5)

Values are presented as number (%).

WBC, white blood cell; HPF, high power field.

Table 3.
Comparison of patients with normal (0–5/HPF) and abnormal WBC count (>5/HPF) in urine microscopic study
Variable White blood cell (/HPF)
≤5 (n=88) >5 (n=303)
Age (yr) 57.1±19.5 58.9±18.5 0.425
Diabetes mellitus 31 (35.2) 87 (28.7) 0.241
Hypertension 35 (39.8) 117 (38.6) 0.844
Chronic kidney disease 3 (3.4) 11 (3.6) 1.000
Symptom duration (hr) 65.4±91.8 70.4±113.7 0.706
Previous antibiotics use 29 (33.0) 33 (10.9) <0.001
Previous APN history 22 (25.0) 70 (23.1) 0.712
Fever 78 (88.6) 283 (93.4) 0.139
Flank pain or back pain 41 (46.6) 128 (42.2) 0.469
CVA tenderness 61 (69.3) 208 (68.7) 0.905
Lower UTI symptom
 Dysuria 31 (35.2) 111 (36.6) 0.809
 Frequency 38 (43.2) 147 (48.5) 0.378
 Urgency 15 (17.0) 74 (24.4) 0.146
 Residual urine sense 25 (28.4) 72 (23.8) 0.374
Laboratory finding
 WBC (counts/μL) 11,566±5,018 12,600±4,653 0.072
 Neutrophil (%) 81±8.9 83.7±7.6 0.006
 NLR 9.9±6.3 13±9.9 0.006
 CRP (mg/dL) 11.1±8 12.6±8.8 0.163
 Procalcitonin (ng/mL) 5.6±14.9 5.7±12.5 0.961
 Positive urine culture 12/26 (46.2) 87/112 (77.7) 0.001
 Ciprofloxacin resistant 8/12 (66.7) 68/87 (78.2) 0.377
 ESBL positive 2/12 (16.7) 22/87 (25.3) 0.514
 Positive blood culture 11/44 (25.0) 69/179 (38.5) 0.093
CT finding
 Abscess formation or emphysematous change 9 (10.2) 15 (5.0) 0.069
 Ureteritis 27 (30.7) 148 (48.8) 0.003
 Cystitis 17 (19.3) 114 (37.6) 0.001

Values are presented as mean ± standard deviation or number (%).

WBC, white blood cell; HPF, high power field; APN, acute pyelonephritis; CVA, costovertebral angle; UTI, urinary tract infection; NLR, neutrophil-to-lymphocyte ratio; CRP, C-reactive protein; ESBL, extended-spectrum β-lactamase; CT, computed tomography.

Table 4.
Logistic regression analysis
WBC of >5/HPF OR (95% CI) p-value Adjusted OR (95% CI) p-value
Previous antibiotics use 0.249 (0.140–0.441) <0.001 0.249 (0.138–0.45)a) <0.001
Fever 1.814 (0.816–4.035) 0.144 1.916 (0.821–4.469)a) 0.133
Flank pain or back pain 0.838 (0.520–1.351) 0.469 1.033 (0.618–1.727)a) 0.900
Dysuria 1.063 (0.647–1.745) 0.809 1.089 (0.63–1.883)a) 0.760
Frequency 1.240 (0.769–2.000) 0.378 1.176 (0.7–1.976)a) 0.539
Residual urine sense 0.785 (0.461–1.339) 0.375 0.904 (0.507–1.611)a) 0.731
Urgency 1.573 (0.851–2.907) 0.149 1.513 (0.787–2.908)a) 0.214
CVA tenderness 0.969 (0.580–1.620) 0.905 1.105 (0.639–1.912)a) 0.721
WBC (×1,000/µL) 1.05 (0.995–1.108) 0.073 1.054 (0.996–1.115)a) 0.068
Neutrophil (%) 1.038 (1.009–1.068) 0.009 1.033 (1.003–1.065)a) 0.030
NLR 1.059 (1.018–1.102) 0.005 1.051 (1.009–1.094)a) 0.017
Lactate 1.140 (0.659–1.973) 0.639 1.04 (0.595–1.817)a) 0.891
CRP 1.021 (0.992–1.051) 0.164 1.014 (0.984–1.045)a) 0.374
Procalcitonin 1.001 (0.977–1.025) 0.960 1.001 (0.975–1.026)a) 0.964
Abscess formation or emphysematous change 0.457 (0.193–1.084) 0.075 0.511 (0.201–1.301)a) 0.159
Ureteritis 2.157 (1.301–3.578) 0.003 2.244 (1.328–3.789)b) 0.003
Unilateral ureteritis 1.574 (0.928–2.672) 0.093 1.645 (0.95–2.848)b) 0.076
Bilateral ureteritis 9.445 (2.226–40.072) 0.002 9.663 (2.239–41.698)b) 0.002
Cystitis 2.519 (1.413–4.490) 0.002 2.412 (1.334–4.36)b) 0.004

WBC, white blood cell; HPF, high power field; OR, odds ratio; CI, confidence interval; CVA, costovertebral angle; NLR, neutrophil-to-lymphocyte ratio; CRP, C-reactive protein.

a) Adjusted for previous antibiotics use, ureteritis, and cystitis.

b) Adjusted for previous antibiotics use.


1. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;52:e103–20.
crossref pmid pmc
2. Kang CI, Kim J, Park DW, Kim BN, Ha US, Lee SJ, et al. Clinical practice guidelines for the antibiotic treatment of community: acquired urinary tract infections. Infect Chemother 2018;50:67–100.
crossref pmid
3. Matthews SJ, Lancaster JW. Urinary tract infections in the elderly population. Am J Geriatr Pharmacother 2011;9:286–309.
crossref pmid pmc
4. Woodford HJ, George J. Diagnosis and management of urinary infections in older people. Clin Med (Lond) 2011;11:80–3.
5. Stamm WE. Measurement of pyuria and its relation to bacteriuria. Am J Med 1983;75(1B):53–8.
6. Colgan R, Williams M, Johnson JR. Diagnosis and treatment of acute pyelonephritis in women. Am Fam Physician 2011;84:519–26.
7. Pietrucha-Dilanchian P, Hooton TM. Diagnosis, treatment, and prevention of urinary tract infection. Microbiol Spectr 2016;4(6):10.1128/microbiolspec.UTI-0021-2015.
crossref pmid
8. Rollino C, Beltrame G, Ferro M, Quattrocchio G, Sandrone M, Quarello F. Acute pyelonephritis in adults: a case series of 223 patients. Nephrol Dial Transplant 2012;27:3488–93.
crossref pmid
9. Ifergan J, Pommier R, Brion MC, Glas L, Rocher L, Bellin MF. Imaging in upper urinary tract infections. Diagn Interv Imaging 2012;93:509–19.
crossref pmid pmc
10. Lee A, Kim HC, Hwang SI, Chin HJ, Na KY, Chae DW, et al. Clinical usefulness of unenhanced computed tomography in patients with acute pyelonephritis. J Korean Med Sci 2018;33:e236.
crossref pmid pmc
11. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 2015;13:269–84.
crossref pmid pmc
12. McLellan LK, Hunstad DA. Urinary tract infection: pathogenesis and outlook. Trends Mol Med 2016;22:946–57.
crossref pmid
13. Expert Panel on Urologic Imaging; Nikolaidis P, Dogra VS, Goldfarb S, Gore JL, Harvin HJ, et al. ACR Appropriateness Criteria® acute pyelonephritis. J Am Coll Radiol 2018;15(11 Suppl):S232–9.
crossref pmid
14. Meng MV, Mario LA, McAninch JW. Current treatment and outcomes of perinephric abscesses. J Urol 2002;168(4 Pt 1):1337–40.
crossref pmid
15. Aboumarzouk OM, Hughes O, Narahari K, Coulthard R, Kynaston H, Chlosta P, et al. Emphysematous pyelonephritis: time for a management plan with an evidence-based approach. Arab J Urol 2014;12:106–15.
crossref pmid
16. Ramsey S, Robertson A, Ablett MJ, Meddings RN, Hollins GW, Little B. Evidence-based drainage of infected hydronephrosis secondary to ureteric calculi. J Endourol 2010;24:185–9.
crossref pmid


Browse all articles >

Editorial Office
170 Hyeonchung-ro, Nam-gu, Daegu 42415, Korea
Tel: +82-53-640-6832    Fax: +82-53-651-0394    E-mail: jyms@yu.ac.kr                

Copyright © 2023 by Yeungnam University College of Medicine, Yeungnam University Institute of Medical Science.

Developed in M2PI

Close layer
prev next